Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.71 |
| ▸ | ATM | Q13315 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | NQO2 | P16083 | 1/20 | 0.55 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466066 | 1.00 | GPR3 (0.71) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL21312375 | 0.95 | GPR3 (0.71) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL29361718 | 0.91 | ATM (0.71) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL85776 | 0.91 | ATM (0.71) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL24548166 | 0.91 | GPR3 (0.73) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL13633648 | 0.88 | ATM (0.57) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL13633670 | 0.88 | ATM (0.57) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL11188527 | 0.87 | ATM (0.56) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL13412880 | 0.86 | GPR3 (0.58) | GPR3ATMHTTMAPTALDH1A1 | |
| SCHEMBL12692761 | 0.84 | ATM (0.58) | GPR3ATMHTTMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115028580-B | Synthesis method of chemiluminescent reagent APS-5 for immunoassay | 北京礼为科技有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117304536-A | Polyarylacridine anion exchange membrane with high ion conductivity and high dimensional stability, and preparation method and application thereof | 安徽大学 | 2023-12-29 | — | — | CN | claimed |
| CN-109928926-B | Improved preparation process of chemical luminescent APS-5 key intermediate | 昆明思安生物科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-115028580-A | Method for synthesizing chemiluminescence reagent APS-5 for immunoassay | 北京礼为科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | claimed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | claimed |
| WO-2018163217-A2 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-09-13 | — | — | WO | claimed |
| CN-106414699-A | system and method for treating a surface | 宝洁公司 | 2017-02-15 | — | — | CN | claimed |
| CN-106414700-A | Consumer product compositions | 宝洁公司 | 2017-02-15 | — | — | CN | claimed |
| CN-105934510-A | Photoactivators | 宝洁公司 | 2016-09-07 | — | — | CN | claimed |
| US-20090093380-A1 | Method of manufacturing polymer array by coating photosensitizer | SAMSUNG ELECTRONICS CO., LTD. | 2009-04-09 | — | — | US | claimed |
| EP-2045004-A1 | Method of manufacturing polymer array by coating photosensitizer | Samsung Electronics Co., Ltd. (KR) | 2009-04-08 | — | — | EP | claimed |
| US-20030044646-A1 | Electroluminescent (EL) devices | XEROX CORPORATION | 2003-03-06 | — | — | US | claimed |
| US-6479172-B2 | PERFORMANCE, THERMOSTABILITY | XEROX CORPORATION | 2002-11-12 | — | — | US | claimed |
| US-20020132134-A1 | Electroluminescent (EL) devices | XEROX CORPORATION | 2002-09-19 | — | — | US | claimed |
| US-5221590-A | Element having conductive layer in contact with acid photogenerating layer containing a dielectric binder and an onium salt photogenerator | EASTMAN KODAK COMPANY (US) | 1993-06-22 | — | — | US | claimed |
| EP-0533910-A1 | PHOTOELECTROGRAPHIC IMAGING WITH DYES OR PIGMENTS TO EFFECT A COLOR DENSITY OR HUE SHIFT | EASTMAN KODAK COMPANY (US) | 1993-03-31 | — | — | EP | claimed |
| WO-1992018905-A1 | PHOTOELECTROGRAPHIC IMAGING WITH DYES OR PIGMENTS TO EFFECT A COLOR DENSITY OR HUE SHIFT | EASTMAN KODAK COMPANY (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0111205-B1 | ACRIDANONE DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1987-04-01 | — | — | EP | claimed |
| US-4544659-A | PARASITICIDES | HOFFMAN-LA ROCHE INC. (US) | 1985-10-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | GPR3 4248/4885ATM 2763/4885HTT 4255/4885 |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | CBR1, POR, CAT | GPR3 4466/4885ATM 3010/4885HTT 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.